Nanogroup (WAR:NNG) ROCE % : -32.70% (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Nanogroup ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nanogroup's annualized ROCE % for the quarter that ended in Sep. 2023 was -32.70%.

Nanogroup ROCE % Historical Data

The historical data trend for Nanogroup's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanogroup ROCE % Chart

Nanogroup Annual Data

Trend

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-12.20

-5.81

-18.92

-47.24

-4.66

Nanogroup Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-42.92	83.82	-39.34	-34.65	-32.70

Nanogroup ROCE % Calculation

Nanogroup's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-0.782	/	( ( (20.302 - 4.504)	+	(19.199 - 1.424) )	/ 2 )
	=	-0.782	/	( (15.798	+	17.775)	/ 2 )
	=	-0.782	/	16.7865
	=	-4.66 %

Nanogroup's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-5.948	/	( ( (19.841 - 1.535)	+	(19.678 - 1.6) )	/ 2 )
	=	-5.948	/	( ( 18.306	+	18.078 )	/ 2 )
	=	-5.948	/	18.192
	=	-32.70 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Nanogroup (WAR:NNG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nanogroup ROCE % Related Terms

Thank you for viewing the detailed overview of Nanogroup's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanogroup (WAR:NNG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanogroup SA (WAR:NNG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rakowiecka 36, Warsaw, POL, 02-532

Website

https://www.nanogroup.eu

Nanogroup SA develops biotechnological and medical projects for diagnostics, therapy and rehabilitation of oncological patients. The company's portfolio includes Nano Velos, Nano Sanguis, and Nano Thea.

Nanogroup (WAR:NNG) Headlines

No Headlines